Prosthetic heart valve

A prosthetic implant with dual frames and multiple fixation mechanisms addresses mixed heart valve diseases, securely anchoring without oversizing, improving patient outcomes.

WO2026236675A1PCT designated stage Publication Date: 2026-11-12CEDARS SINAI MEDICAL CENT
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/US2026/027390
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-09
Filing Date
2026-05-08
Publication Date
2026-11-12

AI Technical Summary

Technical Problem

Existing heart valve replacement technologies, such as Abbott's MitraClip and Edwards Lifesciences' PASCAL system, are limited in addressing mixed valve diseases and often interfere with ventricular function due to single fixation mechanisms that oversize and restrict movement.

Method used

A prosthetic implant with an inner and outer frame configuration, where the inner frame pushes out onto the outer frame, creating a clamping force to anchor the prosthetic implant to native leaflets, utilizing a flexible attachment and multiple fixation mechanisms like tines, hooks, or barbs, to securely attach to the native anatomy without oversizing.

Benefits of technology

The prosthetic implant effectively addresses leakage, narrowing, or mixed diseases in heart valves by securely anchoring without ventricular interference, improving patient outcomes and quality of life.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure US2026027390_12112026_PF_FP_ABST
    Figure US2026027390_12112026_PF_FP_ABST
Patent Text Reader

Abstract

A prosthetic implant includes an inner frame configured for housing bioprosthetic or polymeric leaflets, an outer frame that captures native leaflets / sub valvular apparatus, and a flange that adds additional sealing and fixation. The inner and outer frames are conformable to change an inner diameter in response to assembly process in which the outer frame with a smaller original diameter is attached over an inner frame with a larger original diameter. The outer frame is configured to receive within and flexibly surround the inner frame, the outer frame being conformable to change an outer diameter in response to changes of the inner diameter, the inner diameter of the outer frame being smaller than the outer diameter of the inner frame prior to receiving the inner frame, the diameter of the outer frame expanding to a larger size to accommodate the inner frame.
Need to check novelty before this filing date? Find Prior Art

Description

PROSTHETIC HEART VALVECROSS-REFERENCE TO RELATED APPLICATIONS

[0001] This application claims priority to and the benefit of U.S. Provisional Patent Application No. 63 / 803,062, filed on May 9, 2025, which is incorporated herein by reference in its entirety.FIELD OF INVENTION

[0002] This invention relates generally to devices, systems, and methods for replacing a native heart valve, and specifically to a prosthetic implant with multiple fixation mechanisms that can be delivered via a catheter and associated systems and methods.BACKGROUND OF THE INVENTION

[0003] The following description includes information that may be useful in understanding the present invention. It is not an admission that any of the information provided herein is prior art or relevant to the presently claimed invention, or that any publication specifically or implicitly referenced is prior art.

[0004] There have been attempts to address leaking and / or narrowing aortic, mitral and tricuspid valves. There are currently two ways to address leaking heart valves based on the surgical procedures that are being performed. One way is by repairing the valve and preserving the native leaflets and another way is by replacing the native valve using a bioprosthetic valve. For example, Abbott’s MitraClip™ and Edwards Lifesciences Corporation’s PASCAL system are used to repair the native mitral valves. However, these systems are problematic because they can only address leaking valves, but cannot address mixed valve diseases. Although there have been prosthetic valves that were designed to replace leaking mitral valves, none have been approved by the Food and Drug Administration (FDA) so far. There are FDA approved technologies to address tricuspid disease etiologies. Examples of tricuspid valve systems are Abbott’s TriClip™ Transcatheter Edge-to-Edge device and Edwards Lifesciences Corporation’s EVOQUE system. All of the above-mentioned devices are problematic because they are designed in such a way that they have a single fixation mechanism to the native anatomy, whether it is the annulus dependent on oversizing or leaflet capture. The oversizing dependent anchoring mechanism interferes with the ventricular function and fixates the base by restricting its movement.

[0005] Therefore, there is a clear need for a safe and effective device to repair or replace14938-7152-8601.7065472-001024WQPTheart valves including the mitral valve, tricuspid valve, and aortic valve. In particular, there is a need for improved technologies for addressing different pathologies such as leakage (regurgitation), narrowing (stenosis), or mixed disease (combination of leakage and narrowing). The present disclosure provides a solution for these and other needs that improve patient outcomes and quality of life.SUMMARY

[0006] In one aspect of the present disclosure, a prosthetic implant for a heart valve is provided. In some embodiments, the prosthetic implant includes an inner frame configured to house a prosthetic valve with a plurality of prosthetic leaflets. The prosthetic implant further includes an outer frame. The inner frame pushes out onto the outer frame with a relatively smaller original diameter compared to the inner frame. This will cause the outer frame to expand beyond its outer original diameter and provide a clamping force for anchoring the prosthetic implant to the native leaflets, which are captured between the inner and outer frames of the prosthetic implant. The radial stiffness of the inner frame is slightly higher or equal to the radial stiffness of the outer frame such that post assembly, the outer frame does not reduce the diameter of the inner frame. The small size of the prosthetic implant in the intra-annular and sub-annular space allows the prosthetic valve to actively undersize to the native annulus and the ventricles, eliminating the need for any oversizing.

[0007] In some embodiments, the prosthetic implant includes an outer frame configured for flexible attachment around an anatomical heart valve, the outer frame being conformable to change a size of an inner diameter of the outer frame in response to a size of inner frame attached within it, the inner diameter changing between a first diameter and a second diameter. The first diameter is greater than the second diameter. The size of the outer diameter of the inner frame is initially greater than the size of the inner diameter of the outer frame to cause a clamping force to the anatomical heart valve. In some embodiments, the prosthetic implant further includes a plurality of connection elements, each connection element of the plurality of connection elements providing an attachment point at which the inner frame and the outer frame are joined such that at least portions of the anatomical heart valve are sandwiched between the joined inner frame and outer frame in response to the clamping force.

[0008] In some embodiments, the prosthetic implant further includes a plurality of friction elements such as tines, hooks, or barbs attached to the inner frame, the plurality of friction elements creating a friction fixation when the anatomical heart valve leaflets are received within the inner-receiving space of the prosthetic implant. In one configuration, the 24938-7152-8601.7065472-001024WOPTinner frame and outer frame are designed such that the inner diameter of the outer frame is smaller than the outer diameter of the inner frame. With the attachment of the inner frame and the outer frame at a plurality of attachment locations, the two frames apply radial force into one another, i.e. the inner frame being larger than the outer frame in diameter needs to shrink (crimp) while the outer frame needs to expand. Depending on the stiffness of the two frames, a state of equilibrium is obtained in which the outer diameter of the inner frame and the inner diameter of the outer frame become equal at every axial cross section. In one configuration, the inner frame overpowers the outer frame and stretches the outer frame. In another configuration, both the inner frame and the outer frame change diameters. Either configuration creates an interference fit between the two frames. In this configuration, a plurality of tips emerging from the outer frame encapsulate the combination of fixation elements in form of friction elements such as barbs, tines, or hooks and the interference fit where no independent motion of the captured native leaflets, chords occur.

[0009] In another aspect of the present disclosure, a method for deploying a prosthetic implant within an anatomical heart valve is provided. The method includes inserting a delivery device into a patient to access the patient’s heart, the delivery device carrying the prosthetic implant of any one of the above-mentioned prosthetic implants, the inner frame and the outer frame being in a radially constrained configuration within the delivery device; advancing the delivery device to the anatomical heart valve; and deploying the prosthetic implant at the anatomical heart valve by releasing the inner frame and the outer frame sequentially in response to stepwise separation of a head part of the delivery device from a body part of the delivery device such that the radially constrained outer frame is released and radially expanded, while the proximal end of the inner frame is still constrained inside the delivery catheter, creating an open space between the inner frame and the outer frame to allow the outer frame to encapsulate the native leaflets and or subvalvular apparatus, and then, the radially constrained inner frame is released and radially expanded. When the method is performed, leaflets of the anatomical heart valve are clamped between the radially expanded outer frame and inner frame of the deployed prosthetic implant.

[0010] In some embodiments, the prosthetic implant is configured for mitral and tricuspid valves. In some embodiments, the prosthetic implant further includes a flange that allows axial clamping between the outer frame and the native annulus. The attachment of the flange allows axial clamping and a surface for the native leaflets to touch, thereby helping with sealing. Friction elements on the flange engage with the mitral annular junction or the atrial wall or native anatomy providing additional fixation, thus improving stability and load 34938-7152-8601.7065472-001024WOPTdistribution for the valve.

[0011] The foregoing summary is not intended to represent each embodiment or every aspect of the present disclosure. Rather, the summary merely provides an example of some of the novel aspects and features set forth herein. The above features and advantages, and other features and advantages of the present disclosure, will be readily apparent from the following detailed description of representative embodiments and modes for carrying out the present approach, when taken in connection with the accompanying drawings and the appended claims.BRIEF DESCRIPTION OF DRAWINGS

[0012] The accompanying drawings, which are incorporated in and constitute a part of this specification, exemplify the embodiments of the present invention and, together with the description, serve to explain and illustrate principles of the invention. The drawings are intended to illustrate major features of the exemplary embodiments in a diagrammatic manner. The drawings are not intended to depict every feature of actual embodiments nor relative dimensions of the depicted elements, and are not drawn to scale.

[0013] FIG. 1A illustrates a side view of a prosthetic implant for a heart valve, according to an embodiment of the disclosure.

[0014] FIG. IB illustrates a top view of the prosthetic implant illustrated in FIG. 1 A, according to an embodiment of the disclosure.

[0015] FIG. 1C illustrates a structural relationship of an inner frame and an outer frame of the prosthetic implant illustrated in FIGS. 1A and IB, according to an embodiment of the disclosure.

[0016] FIG. ID illustrates configurations of an outer frame profile, according to an embodiment of the disclosure.

[0017] FIG. IE illustrates configurations of an inner frame profile, according to an embodiment of the disclosure.

[0018] FIG. 2A is a schematic illustration of a portion of an outer frame, according to an embodiment of the disclosure.

[0019] FIG. 2B is a schematic illustration of portions of an inner frame and an outer frame of a prosthetic implant for a heart valve, according to an embodiment of the disclosure.

[0020] FIG. 2C is a schematic illustration of a prosthetic implant deployed at a heart valve, according to an embodiment of the disclosure.

[0021] FIG. 3A illustrates various views (top and perspective views) of a prosthetic implant for a heart valve, according to an embodiment of the disclosure.44938-7152-8601.7065472-001024WOPT

[0022] FIG. 3B illustrates various views (top and side perspective views) of a prosthetic implant for a heart valve with a covering, according to an embodiment of the disclosure.

[0023] FIG. 4A illustrates an expanded outer frame of a prosthetic implant deployed at a ventricular side of a heart valve, according to an embodiment of the disclosure.

[0024] FIG. 4B illustrates two different views of an expanded inner frame and an expanded flange of a prosthetic implant deployed at an atrial side of a heart valve, according to an embodiment of the disclosure.

[0025] FIG. 5 is a flowchart illustrating a method for delivering a prosthetic implant to a heart valve of an individual, according to an embodiment of the disclosure.

[0026] FIG. 6A is a schematic illustrating separation of two parts of a delivery device containing a prosthetic implant, according to an embodiment of the disclosure.

[0027] FIG. 6B is a schematic illustrating further separation of the two parts of the delivery device illustrated in FIG. 6A, according to an embodiment of the disclosure.

[0028] FIG. 6C is a schematic side view of a delivery device illustrating releasing an outer frame from the delivery device, according to an embodiment of the disclosure.

[0029] FIG. 6D illustrates an outer frame of a prosthetic implant released from a delivery device while an inner frame remains in the delivery device, according to an embodiment of the disclosure.

[0030] FIG. 6E illustrates the expanded outer frame and the constrained inner frame without the delivery device illustrated in FIG. 6D, according to an embodiment of the disclosure.

[0031] FIG. 7 is a schematic illustrating a prosthetic implant deployed at a native heart valve, according to an embodiment of the disclosure.

[0032] FIG. 8 illustrates a clamping mechanism of a prosthetic implant, according to an embodiment of the disclosure.

[0033] FIG. 9 illustrates axial clamping of a prosthetic implant, according to an embodiment of the disclosure.

[0034] FIG. 10 illustrates attachment of the inner frame and the flange of a prosthetic implant to create axial clamping, according to an embodiment of the disclosure.

[0035] FIG. 11 illustrates various flange designs, according to an embodiment of the disclosure.

[0036] FIG. 12A illustrates a cross-section view of a prosthetic implant for a heart valve with 9 anchors in a first configuration, according to an embodiment of the disclosure.54938-7152-8601.7065472-001024WOPT

[0037] FIG. 12B illustrates a front / side view of the prosthetic implant shown in FIG.12A, according to an embodiment of the disclosure.

[0038] FIG. 13 A illustrates 3 frames of the prosthetic implant shown in FIG. 12A in a second configuration, according to an embodiment of the disclosure.

[0039] FIG. 13B illustrates a cross-section view of the 3 frames shown in FIG. 13 A, according to an embodiment of the disclosure.

[0040] FIG. 14A illustrates a front / side view of a prosthetic implant for a heart valve with 9 anchors, according to an embodiment of the disclosure, the prosthetic implant having a lower crimp profile compared to a crimp profile of the prosthetic implant shown in FIGS. 12A and 12B.

[0041] FIG. 14B illustrates 3 frames of the prosthetic implant shown in FIG. 14 A, according to an embodiment of the disclosure.

[0042] FIG. 14C illustrates a cross-section view of the 3 frames show in FIG. 14B, according to an embodiment of the disclosure.

[0043] FIG. 15A illustrates a front / side view of a prosthetic implant for a heart valve with 9 anchors, according to an embodiment of the disclosure, the prosthetic implant including a flange and an inner frame.

[0044] FIG. 15B illustrates the prosthetic implant shown in FIG. 15A in which the flange is attached to the inner frame using sutures, according to an embodiment of the disclosure.

[0045] FIG. 15C illustrates a magnified view of the boxed portion shown in FIG. 15B, according to an embodiment of the disclosure.

[0046] FIG. 15D illustrates a front / side view of a prosthetic implant, according to another embodiment of the disclosure.

[0047] FIG. 16A illustrates a front / side view of a prosthetic implant for a heart valve with 9 anchors in which foam is attached to a first part of the prosthetic implant, according to an embodiment of the disclosure.

[0048] FIG. 16B illustrates a front / side view of a prosthetic implant for a heart valve with 9 anchors in which foam is attached to a second part of the prosthetic implant, according to an embodiment of the disclosure.

[0049] FIG. 16C illustrates a front / side view of a prosthetic implant for a heart valve with 9 anchors in which foam is attached to a third part of the prosthetic implant, according to an embodiment of the disclosure.64938-7152-8601.7065472-001024WOPT

[0050] FIG. 17 illustrates the prosthetic implant shown in FIG. 16A deployed at a native heart valve, according to an embodiment of the disclosure.

[0051] FIG. 18A illustrates a helical spring seal, according to an embodiment of the disclosure.

[0052] FIG. 18B illustrates a zig zag pattern of a wire in the helical spring seal shown in FIG. 18 A, according to an embodiment of the disclosure.

[0053] FIG. 18C illustrates a prosthetic implant with a compressible helical spring ring against native annulus / native leaflets, according to an embodiment of the disclosure.

[0054] FIG. 18D illustrates a side view of the prosthetic implant shown in FIG. 18C, according to an embodiment of the disclosure.

[0055] FIG. 19A illustrates an anchor tip of a stent anchor, according to an embodiment of the disclosure.

[0056] FIG. 19B illustrates an M-shaped anchor tip of a stent anchor, according to another embodiment of the disclosure.

[0057] FIG. 19C illustrates a roof style anchor tip of a stent anchor, according to yet another embodiment of the disclosure.

[0058] FIG. 20A illustrates an exemplary outer frame or an anchor of a prosthetic implant, according to an embodiment of the disclosure.

[0059] FIG. 20B illustrates an exemplary prosthetic implant including the outer frame shown in FIG. 20A, according to an embodiment of the disclosure.

[0060] FIG. 21 A illustrates capturing of native leaflets by a stent anchor with a first type of anchor tip, according to an embodiment of the disclosure.

[0061] FIG. 2 IB illustrates capturing of native leaflets by a stent anchor with a second type of anchor tip, according to an embodiment of the disclosure.

[0062] FIG. 21C illustrates capturing of native leaflets by a stent anchor with a third type of anchor tip, according to an embodiment of the disclosure.

[0063] FIG. 22A illustrates frames of a prosthetic implant including a flange with eyelets, according to an embodiment of the disclosure.

[0064] FIG. 22B illustrates a flange corresponding to the flange shown in FIG. 22A, according to an embodiment of the disclosure.

[0065] FIG. 22C illustrates a portion of a delivery device / catheter, according to an embodiment of the disclosure.

[0066] FIG. 23 A illustrates frames of a prosthetic implant including a flange with double eyelets, according to an embodiment of the disclosure.74938-7152-8601.7065472-001024WOPT

[0067] FIG. 23B illustrates a magnified perspective view of the double eyelets shown in FIG. 23 A, according to an embodiment of the disclosure.

[0068] FIG. 23C illustrates a side view of a portion of the flange shown in FIGS. 23A and 23B and a side view and a perspective view of the portion with a suture loop and suture knots, or wire, according to an embodiment of the disclosure.

[0069] FIG. 24A illustrates an arrangement of windows on an atrial flange outflow of a flange, according to an embodiment of the disclosure.

[0070] FIG. 24B illustrates a magnified view of a portion of the box shown in FIG.24A, the flange and an outer frame being shown individually, according to an embodiment of the disclosure.

[0071] FIG. 24C illustrates various ways of attaching a coupler to the flange and the outer frame, according to an embodiment of the disclosure.

[0072] FIG. 24D illustrates a single flange and a single outer frame in the box of FIG.24A, according to an embodiment of the disclosure.

[0073] FIG. 24E illustrates a change of the configuration of the flange and the outer frame in response to operation of a delivery catheter, according to an embodiment of the disclosure.

[0074] FIG. 24F illustrates a pseudo pin joint created by the frame geometry, according to an embodiment of the disclosure.

[0075] While the present disclosure is susceptible to various modifications and alternative forms, specific implementations and embodiments have been shown by way of example in the drawings and will be described in detail herein. It should be understood, however, that the present disclosure is not intended to be limited to the particular forms disclosed. Rather, the present disclosure is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the present disclosure as defined by the appended claims.DETAILED DESCRIPTION OF THE INVENTION

[0076] Unless defined otherwise, technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Szy cher’s Dictionary of Medical Devices CRC Press, 1995, may provide useful guidance to many of the terms and phrases used herein. One skilled in the art will recognize many methods and materials similar or equivalent to those described herein, which84938-7152-8601.7065472-001024WOPTcould be used in the practice of the present invention. Indeed, the present invention is in no way limited to the methods and materials specifically described.

[0077] In some embodiments, properties such as dimensions, shapes, relative positions, and so forth, used to describe and claim certain embodiments of the invention are to be understood as being modified by the term “about.” For purposes of the present detailed description, unless specifically disclaimed, and where appropriate, the singular includes the plural and vice versa. The word “including” means “including without limitation.” Moreover, words of approximation, such as “about,” “almost,” “substantially,” “approximately,” and the like, can be used herein to mean “at,” “near,” “nearly at,” “within 3-5% of,” “within acceptable manufacturing tolerances of,” or any logical combination thereof. Similarly, terms “vertical” or “horizontal” are intended to additionally include “within 3-5% of’ a vertical or horizontal orientation, respectively. Additionally, words of direction, such as “top,” “bottom,” “left,” “right,” “above,” and “below” are intended to relate to the equivalent direction as depicted in a reference illustration; as understood contextually from the object(s) or element(s) being referenced, such as from a commonly used position for the object(s) or element(s); or as otherwise described herein.

[0078] Various examples of the invention will now be described. The following description provides specific details for a thorough understanding and enabling description of these examples. One skilled in the relevant art will understand, however, that the invention may be practiced without many of these details. Likewise, one skilled in the relevant art will also understand that the invention can include many other obvious features not described in detail herein. Additionally, some well-known structures or functions may not be shown or described in detail below, so as to avoid unnecessarily obscuring the relevant description.

[0079] The terminology used below is to be interpreted in its broadest reasonable manner, even though it is being used in conjunction with a detailed description of certain specific examples of the invention. Indeed, certain terms may even be emphasized below; however, any terminology intended to be interpreted in any restricted manner will be overtly and specifically defined as such in this Detailed Description section.

[0080] While this specification contains many specific implementation details, these should not be construed as limitations on the scope of any inventions or of what may be claimed, but rather as descriptions of features specific to particular implementations of particular inventions. Certain features that are described in this specification in the context of separate implementations can also be implemented in combination in a single implementation. Conversely, various features that are described in the context of a single implementation can 94938-7152-8601.7065472-001024WOPTalso be implemented in multiple implementations separately or in any suitable subcombination. Moreover, although features may be described above as acting in certain combinations and even initially claimed as such, one or more features from a claimed combination can in some cases be excised from the combination, and the claimed combination may be directed to a subcombination or variation of a subcombination.

[0081] Similarly, while operations may be depicted in the drawings in a particular order, this should not be understood as requiring that such operations be performed in the particular order shown or in sequential order, or that all illustrated operations be performed, to achieve desirable results. In certain circumstances, multitasking and parallel processing may be advantageous. Moreover, the separation of various system components in the implementations described above should not be understood as requiring such separation in all implementations, and it should be understood that the described program components and systems can generally be integrated together in a single software product or packaged into multiple software products.

[0082] One skilled in the art will recognize many methods and materials similar or equivalent to those described herein, which could be used in the practice of the present invention. Indeed, the present invention is in no way limited to the methods and materials described. For purposes of the present invention, the following terms are defined below.

[0083] In various embodiments, the devices, systems and methods described herein are configured for humans. One of skill in the art would readily appreciate that the devices, systems and methods described herein could be customized for use in almost any mammal in which a heart valve may be replaced. In various embodiments, the device is delivered transcatheterly, e.g. via, transjugular, transfemoral, or transapical access.

[0084] “Mammal” as used herein refers to any member of the class Mammalia, including but not limited to, humans, domestic animals, farm animals, zoo animals, sport animals, pet animals such as dogs, cats, guinea pigs, rabbits, rats, mice, horses, cattle, cows; primates such as apes, monkeys, orangutans, and chimpanzees; canids such as dogs and wolves; felids such as cats, lions, and tigers; equids such as horses, donkeys, and zebras; food animals such as cows, pigs, and sheep; ungulates such as deer and giraffes; rodents such as mice, rats, hamsters and guinea pigs; and so on. In certain embodiments, the mammal is a human subject. The term does not denote a particular age or sex. Thus, adult and newborn subjects, as well as fetuses, whether male or female, are intended to be included within the scope of this term.

[0085] In various embodiments, the appropriate guide wires, sheaths and catheters for 104938-7152-8601.7065472-001024WOPTuse with the devices, systems and methods described herein will be apparent to a person of skill in the art, for example, as described in Ye et al. (Transapical aortic valve implantation in humans. Ye J, Cheung A, Lichtenstein SV, Carere RG, Thompson CR, Pasupati S, Webb JG. J Thorac Cardiovasc Surg. 2006 May; 131(5): 1194-6), Lichtenstein et al. (Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Lichtenstein SV, Cheung A, Ye J, Thompson CR, Carere RG, Pasupati S, Webb JG. Circulation. 2006 Aug 8; 114 (6):591-6. Epub 2006 Jul 31), Kurra et al. (Pre-procedural imaging of aortic root orientation and dimensions: comparison between X-ray angiographic planar imaging and 3-dimensional multidetector row computed tomography. Kurra V, Kapadia SR, Tuzcu EM, Halliburton SS, Svensson L, Roselli EE, Schoenhagen P. JACC Cardiovasc Interv. 2010 Jan;3 (1): 105-13.), Wake et al. (Computed tomography angiography for transcatheter aortic valve replacement. Wake N, Kumamaru K, Prior R, Rybicki FJ, Steigner ML. Radiol Technol. 2013 Mar-Apr;84(4):326-40.), and Little et al. (Multimodality noninvasive imaging for transcatheter aortic valve implantation: a primer. Little SH, Shah DJ, Mahmarian JJ. Methodist Debakey Cardiovasc J. 2012 Apr-Jun;8(2):29-37.), all of which are incorporated by reference herein in their entirety as fully set forth.

[0086] FIGS. 1A-1E show an example of a prosthetic implant 100 that can replace or supplement an anatomical or native heart valve. For example, the prosthetic implant 100 may be used in two or three different chambers of the heart to address more than one pathology, including leakage (regurgitation), narrowing (stenosis), or mixed disease (combination of leakage and narrowing). The prosthetic implant 100 includes an inner frame 110 configured to house the bioprosthetic or polymeric leaflets 180 (shown in FIG. 3B). In some embodiments, the inner frame 110 houses a tri-leaflet bioprosthetic tissue valve.

[0087] Referring to FIG. 1C, the inner frame 110 has an original diameter ODI1 that has an original size prior to being assembled to the prosthetic implant 100 and / or prior to attachment or fixation around the anatomical heart valve. The ODI1 diameter, which refers to the outer diameter of the inner frame 110, is flexible to change in response to the attachment of an outer frame 120 of smaller inner diameter (IDO1).

[0088] According to some embodiments, a height of the inner frame 110 is small enough to accommodate fitting a prosthetic heart valve with sufficient effective orifice area, while preserving a short crimp length in order to accommodate for various native anatomies.

[0089] The inner frame 110 is optionally a shape-memory metal that self-adjusts to an original shape or size after being subjected to a change based on a force. For example, a shapememory metal includes a material having a spring-bias property. Thus, the material from which 114938-7152-8601.7065472-001024WOPTthe inner frame 110 is fabricated allows the inner frame 110 to automatically expand to its functional size and shape when deployed but also allows the inner frame 110 to be radially compressed or constrained to a smaller profile for delivery through the patient's vasculature. In other embodiments, the inner frame 110 is made from various biocompatible materials, such as nickel titanium alloys (e.g., nitinol) or any other compatible material.

[0090] The prosthetic implant 100 further includes an outer frame 120 configured to receive within and flexibly surround the inner frame 110. The outer frame 120 may also be referred to as an anchor frame and the terms “outer frame” and “anchor frame” may be used interchangeably. The outer frame 120 is conformable to change a size of an inner diameter of the outer frame 120 in response to being assembled over the inner frame 110. The original inner diameter IDO1 of the outer frame 120 is generally smaller than the original outer diameter ODI1 of the inner frame 110 prior receiving the inner frame 110 within the outer frame 120, as illustrated in FIG. 1C. To assemble the prosthetic implant 100, the inner diameter of the outer frame 120 needs to be expanded to a larger size than the outer diameter of the inner frame 110 after receiving within the inner frame 110. For example, as illustrated in FIG. 1C, the original outer diameter ODI1 of the inner frame 110 is larger than the original inner diameter of the outer frame 120, IDO1 (original / pre-assembly). After the assembly of the outer frame 120 and inner frame 110 (post-assembly), the assembled outer diameter of the inner frame 110, ODI2, is equal to the assembled inner diameter of the outer frame 120, IDO2.

[0091] In some embodiments, the prosthetic implant 100 is constructed by a friction fit, an interference fit, or a press fit in which two components, i.e., the inner frame 110 and the outer frame 120, are joined by forcing one into the other, creating a tight fit held together by fictional forces. This method relies on the friction generated between the two components 110, 120 to maintain their position and secure them together. Therefore, no fastening mechanism is required for construction of the prosthetic implant 100.

[0092] Referring to FIG. 1C, IDO1 + 2*WT0 = ODO1; IDI1 + 2*WTI = ODI1; and IDO1 < ODI1. Further, IDO2 + 2*WT0 = ODO2; IDI2 + 2*WTI = ODI2; and IDO2 = ODI2 (WTO = Wall thickness of the outer frame 120, WTI = Wall thickness of the inner frame 110).

[0093] Referring to FIG. ID, the two flared configurations potential profiles for the outer frame 120 could serve as additional features. The “flared in tip” enhances the radial clamping and interference fit between the inner frame 110 and outer frames 120 at the 6, 9, 12, 18 or 24 potential tips of the outer frame 120. This makes sure that in case the native leaflet is only captured at the tip of the outer frame 120, the clamping force is enough to properly secure the leaflet between the two frames 110, 120. The “flared out tip” is a configuration that helps 124938-7152-8601.7065472-001024WOPTincreasing the outer frame diameter during the leaflet capturing step of the deployment procedure, providing 1-3 mm larger window to allow for capturing shorter leaflets, or large coaptation gaps.

[0094] Referring to FIG. IE, the two flared configurations potential profiles for the inner frame 110 could serve as additional features. The “flared out tip” for the inner frame 110 enhances the radial clamping and interference fit between the inner frame 110 and outer frames 120 at the 6, 9, 12, 18 or 24 potential tips of the outer frame 120. This makes sure that in case the native leaflets were only captured at the tip of the outer frame 120, the clamping force is enough to properly secure the leaflet between the two frames 110, 120.

[0095] The height of the inner frame 110 is greater than the height of the outer frame 120. In some embodiments, the entire height of the outer frame 120 overlaps a portion of the height of the inner frame 110.

[0096] The outer frame 120 is optionally a shape-memory metal. For example, a shapememory metal includes a material having a spring-bias property. Thus, the material from which the outer frame 120 is fabricated allows the outer frame 120 to automatically expand to its functional size and shape when deployed but also allows the outer frame 120 to be radially compressed or constrained to a smaller profile for delivery through the patient's vasculature. In other embodiments, the outer frame 120 is made from various biocompatible materials, such as nickel titanium alloys (e.g., nitinol). In some embodiments, the inner frame 110 and the outer frame 120 are made from the same material. Even if the inner frame 110 and the outer frame 120 are made from the same material, stiffness of the two frames may be different. In alternative embodiments, the inner frame 110 and the outer frame 120 are made from different materials.

[0097] Since the inner frame 110 and the outer frame 120 are compressible / expandable, the inner frame 110 can be forcibly received / surrounded by the outer frame 120 that has a smaller original inner diameter IDO1. Due to stretching and shrinking of any one or both of these two frames 110, 120, and the interference fit created in the sub-assembly, a clamping force is enhanced in the assembled prosthetic implant 100. When the inner frame 110 is received within the outer frame 120, as in the assembled prosthetic implant 100, the resulting inner diameter of the prosthetic implant 100 can be smaller than the original inner diameter of the inner frame 110. In another configuration, the radial stiffness of the inner frame 110 can be higher than that of the outer frame 120 such that the inner frame diameter stays the same, while the outer frame 120 expands to allow for the outer frame 120 to fit over the inner frame 110. In some embodiments, the inner diameter of the prosthetic implant 100 is dependent on the 134938-7152-8601.7065472-001024WOPTstiffness of the inner and outer frames 110, 120 in comparison with each other. In one configuration, the stiffness of the outer frame 120 is higher than the stiffness of the inner frame 110 and the inner diameter of the assembled implant 100 becomes smaller than that of the preassembled inner frame 110. In another embodiment, the inner frame 110 is stiffer than the outer frame 120 and the outer frame expands to accommodate the inner frame 110 inside it, causing the implant 100 to have an inner diameter similar to that of the inner frame 110. In another embodiment, both the inner and outer frames 110, 120 change diameters to find an equilibrium, where the inward radial force from the expanded outer frame 120 equals the outward radial force of the shrunk inner frame 110. Although the original outer diameter of the inner frame 110, ODI1, is greater than the original inner diameter of the outer frame 120, IDO1, by about 1-3 mm, prior to the outer frame 120 receiving the inner frame 110 for assembly of the prosthetic implant 100, as shown in FIG. 1C, the outer frame 120 stretches to receive within the inner frame 110, the inner frame 110 shrinks for the outer frame 120 to receive within the inner frame 110, or the outer frame 120 stretches and the inner frame 110 shrinks for the outer frame 120 to receive within the inner frame 110. In some embodiments, the outer frame 120 is in direct contact with the inner frame 110 when the inner frame 110 is received within the outer frame 120. The inner frame 110 and the outer frame 120 of the prosthetic implant 100 are crimped such that post-expansion, a clamping force is generated between the inner frame 110 and the outer frame 120. Thus, the inner frame 110 and the outer frame 120 are configured to secure leaflets or in general, the subvalvular apparatus, of the anatomical heart valve between the inner frame 110 and the outer frame 120 in response to deployment of the prosthetic implant 100 at the anatomical heart valve.

[0098] When assembling the outer frame 120 over the inner frame 110, the inner diameter of the outer frame 120 being smaller than the outer diameter of the inner frame 110 results in expansion of the outer frame 120. The expansion of the outer frame 120 results in tensile pre-strain which leads to compressive residual stresses, which enhances the fatigue durability of the outer frame 120 and improves crack resistance. To improve the fatigue durability of the metal, the outer frame 120 will be expanded beyond its set diameter to create tension in the metal (nitinol), thereby making it more fatigue resistant. This will allow the outer frame 120 to slide onto the inner frame 110 like a sleeve during valve assembly. The prosthetic implant 100 actively undersizes to the native anatomy and does not require annular or ventricular oversizing for anchoring.

[0099] Normally, the mitral valve has two leaflets situated between the left atrium and the left ventricle. Typically, the tricuspid valve has three leaflets, positioned between the right 144938-7152-8601.7065472-001024WOPTatrium and the right ventricle. Normally, the aortic valve has three leaflets, located between the left ventricle and the aorta. The prosthetic implant 100 may be used in any of the mitral valve, tricuspid valve, and aortic valve. When the prosthetic implant 100 is deployed to these heart valves, leaflets of the heart valves, or the subvalvular apparatus in case of the mitral and tricuspid valves, are clamped between the inner frame 110 and the outer frame 120 that are released from a delivery device 600 or delivery catheter (shown in FIGS. 6 A and 6B) sequentially.

[0100] The prosthetic implant 100 further includes a plurality of connection elements 130 attaching the inner frame 110 with the outer frame 120. Referring to FIG. 1A, each connection element of the plurality of connection elements 130 provides an attachment point at which the inner frame 110 and the outer frame 120 are joined. In some embodiments, the connection element 130 includes suturing of the inner frame 110 and the outer frame 120 at the attachment point. The inner frame 11 and the outer frame 120 attached via the plurality of connection elements 130 are configured to be in close contact with each other when the inner frame 110 and the outer frame 120 are released and expanded sequentially at the anatomical heart valve. As a result, the native leaflets of the anatomical heart valve are clamped between the inner frame 110 and the outer frame 120.

[0101] In some embodiments, the outer frame 120 is shaped such that the inner diameter of the outer frame 120 increases incrementally from a bottom end to a top end of the outer frame 120, as shown in FIG. ID (flared out tip). In these embodiments, a top inner diameter of the outer frame 120 is greater than a bottom inner diameter of the outer frame 120. For example, the top inner diameter is greater than the bottom inner diameter by about 1-3 mm, as shown in FIG. ID.

[0102] In some embodiments, the outer frame 120 is generally cylindrical, the inner diameter of the outer frame 120 being generally consistent from a bottom end to a top end of the outer frame 120, as shown in FIG. ID (cylindrical configuration).

[0103] Generally, as shown in FIG. IE (cylindrical configuration), the inner frame 110 is cylindrical such that the inner diameter of the inner frame 110 is generally consistent from a bottom end to a top end of the inner frame 110. For example, the inner diameter of the inner frame 110 is in a range of about 22 mm to about 31 mm, and the inner diameter of the outer frame 120 is in a range of about 20 mm to about 31 mm, prior to the outer frame 120 receiving the inner frame 110 within the inner diameter of the outer frame 120. The prosthetic implant 100 may be manufactured in multiple sizes having various inner diameters of the inner frame 110 and outer frame 120 to accommodate various patient anatomies in which the prosthetic 154938-7152-8601.7065472-001024WOPTimplant 100 is implanted.

[0104] Referring back to FIG. 1 A, in some embodiments, the inner frame 110 has tissue engaging elements or friction elements 140, 150 attached thereto. Tissue engaging elements 140, 150 include any feature that engages tissue in an atraumatic manner such as a blunt element, or which partially pierces or fully penetrates cardiac tissue or native leaflet. Tissue engaging elements 140, 150 may take the form of spikes, barbs, tines, hooks or any structure known in art capable of piercing cardiac tissue, or alternatively, any blunt or atraumatic feature configured to apply pressure on the cardiac tissue without piercing the tissue. Although there are two different types of tissue engaging elements 140, 150, including downward tissue engaging elements 140 and upward tissue engaging elements 150, in FIG. 1A, the prosthetic implant 100 may have only one type of tissue engaging elements 140 or 150. In some embodiments, only downward tissue engaging elements 140 are attached to the inner frame 110. The plurality of tissue engaging elements 140, 150 create a friction fixation with the leaflets of the anatomical heart valve (mitral, tricuspid, or aortic) that are already fixated by the clamp action created by the inner frame 110 and the outer frame 120, thus, providing an additional fixation. Based on the native heart valve to which the prosthetic implant 100 is deployed, an appropriately sized prosthetic implant 100 may be used according to the anatomy of the patient’s native heart valve.

[0105] Further referring to FIGS. 1A and IB, in some embodiments, the prosthetic implant 100 further includes a flange 160 arranged around the inner frame 110. The flange 160 includes a plurality of flange elements 162 connected to each other. For example, in FIG. IB, there are 24 flange elements 162 forming the flange 160. However, the number of flange elements 162 is not limited thereto. For example, there may be 18 flange elements, instead of 24, as described below in other embodiments directed to 9-anchor prosthetic implants. The reduced number of points from 24 to 18 allows a prosthetic implant to crimp to a smaller diameter, thus reducing the crimp profile of the prosthetic implant.

[0106] A tissue engaging element 164, such as a barb, hook or tine, may be attached to or formed on the outer surface of each flange element 162. The flange 160 is an atrial part attached to the inner frame 110 via connectors 166. The connectors 166 are designed such that they allow axial interference between the tip of the outer frame 120 and flange 160. For example, connectors 166 may connect only some of the flange elements 162 to the inner frame 110. For example, in FIG. IB, 6 connectors 166 are shown. However, the number of the connectors 166 is not limited to 6, and the number may be greater or less than 6, depending on the number of flange elements 162. The flange 160 may be curved inwards and ventricular 164938-7152-8601.7065472-001024WOPTfacing apices of the atrial flange 160 are configured to rest on top of the mitral and tricuspid valve annulus. The flange 160 is configured to engage a wall of an atrium or mitral annulus atrial junction in response to deployment of the prosthetic implant 100 at the anatomical heart valve. For example, the anatomical heart valve is a mitral valve or a tricuspid valve in this case. The plurality of tissue engaging elements 164 formed on the flange 160 are configured to create a friction fixation with the wall of the atrium. A plurality of eyelets 168 are formed at the top of the flange 160. Eyelets 168 are used to attach the valve to the catheter system.

[0107] In alternative embodiments, the prosthetic implant 100 does not include the flange 160 (two-frame construction). This prosthetic implant 100 lacking the flange 160 is compatible for Aortic Regurgitation (AR) because the flange 160 is not required. For example, the inner frame 110 of the prosthetic implant 100 for this configuration has 3 segments (as opposed to the 6, 9, or 12 or any other number of segments used for mitral and tricuspid valves). Each anchor / segment of the prosthetic implant 100 in this configuration is configured to capture one of the leaflets of the aortic valve and sits inside the cusp of the native aortic valve. The inner frame 110 then expands, and the leaflets of the native aortic valve get sandwiched between the inner frame 110 and the outer frame 120. Further, the tissue engaging elements of 140 / 150 of the inner frame 110 will also provide fixation in addition to the clamping.

[0108] Referring to FIGS. 2A and 2B in addition to FIGS. 1 A-1C, the outer frame 120 may include anchoring portioning portions 122 for anchoring on the surface of the native heart valve. For example, the diameter of the outer frame 120 shown in FIG. 2A is in the range of 25-29 mm, when the prosthetic implant 100 is deployed in the native heart valve. However, the diameter is not limited thereto, and the range may be less or greater than the above-identified range. In some embodiments, there are 6 circumferential points of contact between the inner frame 110 and the outer frame 120. However, the number of the circumferential points is not limited to 6, and the number may be 3 for the prosthetic implant 100 used for the native aortic valve. Or the number of the circumferential points may be 9 or 12 for the prosthetic implant 100 used for the native mitral and tricuspid valves. A prosthetic implant with 9 circumferential points of contact between the inner frame and the outer frame, i.e., 9-anchor construction, will be discussed later.

[0109] FIG. 2C illustrates a prosthetic implant 100 deployed at the native heart valve. When deployed, the inner frame 110 is located at the ventricular side of the native heart valve and the outer frame 120 extends from the ventricular side to the atrial side of the native heart valve. A prosthetic implant 100 with appropriately sized diameter may be used based on the patient's anatomy of the aortic, mitral, or tricuspid valve. For example, the diameter of the inner 174938-7152-8601.7065472-001024WOPTframe 110 is in the range of 20-30 mm, when the prosthetic implant 100 is deployed in the native heart valve. However, the diameter is not limited thereto, and the range may be less or greater than the above-identified range.

[0110] FIG. 3 A illustrates various views of expanded prosthetic implant 100. As shown in FIG. 3B, in some embodiments, the prosthetic implant 100 is at least partially covered by a covering 170. Any suitable lightweight, strong, fluid impervious, biocompatible material may be utilized as the covering 170. The covering 170 may be attached in any suitable manner and by any suitable means to the inner frame 110, outer frame 120, and / or flange 160. For example, the covering 170 is attached to the frame 110 / 120 utilizing sutures, staples, chemical / heat bonding and / or adhesive. In certain embodiments, the covering is fabric.[oni] Further, in some embodiments, the prosthetic implant 100 includes a plurality of bioprosthetic or prosthetic leaflets 180, as exemplified in FIG. 3B. The inner frame 100 houses the plurality of leaflets 180. That is, the plurality leaflets 180 are housed in an inner-receiving space of the inner frame 110 to regulate blood flow by opening and closing the valve. In some embodiments, the bioprosthetic or prosthetic leaflets 180 are made from very durable, biocompatible materials such as pyrolytic carbon or metal alloys (e.g., titanium or stainless steel). The metal alloys may be used in combination with pyrolytic carbon coatings. In some embodiments, the bioprosthetic or prosthetic leaflets 180 are made from biological tissues sourced from bovine pericardium, porcine heart valve tissue, or equine pericardium. In some embodiments, the bioprosthetic or prosthetic leaflets 180 are made from synthetic polymers.

[0112] FIG. 4 A illustrates a portion of the prosthetic implant 100 deployed at the ventricular side of the native heart valve. Referring to FIG. 4A, when the prosthetic implant 100 is deployed to the native heart valve, the outer frame 120 is released and expanded at the ventricular side to contact the leaflets of the native heart valve. Although not shown in FIG.4 A, the inner frame 110 and the outer frame 120 clamp the leaflets of the native heart valve for fixation of the prosthetic implant 100 at the native heart valve. FIG. 4B illustrates a portion of the prosthetic implant 100 deployed at the atrial side of the native heart valve. Referring to FIG.4B, the inner frame 110 and the flange 160 of the deployed prosthetic implant 100 are released and expanded at the atrial side, the flange 160 resting on top of the native heart valve (mitral valve or tricuspid valve) for fixation. The inner frame 110 and the flange 160 connect the atrium and the ventricle of the native heart valve.

[0113] As discussed above, the prosthetic implant 100 may or may not include the flange 160 in addition to the inner frame 110 and the outer frame 120, depending on the type of the heart valve to which the prosthetic implant 100 is deployed. Further, the prosthetic 184938-7152-8601.7065472-001024WOPTimplant 100 may not have leaflets. Rather, each of the plurality of connection elements 130, along with the inner frame 110 and the outer frame 120, is configured to capture one of leaflets of the anatomical heart valve in response to deployment of the prosthetic implant 100 into the anatomical heart valve. For example, when the anatomical heart valve is an aortic valve, and the prosthetic implant 100 may have 2 or 3 attachment points between the inner frame 110 and the outer frame 120. When the anatomical heart valve is a mitral valve or a tricuspid valve, the prosthetic implant 100 may have 6, 9, or 12 or any other number of attachment points between the inner frame 110 and the outer frame 120. The prosthetic implant 100 including the flange 160 is configured to clamp leaflets of the mitral valve or the tricuspid valve between the inner frame 110 and the outer frame 120 in response to deployment of the prosthetic implant 100 at the mitral valve or the tricuspid valve. In this case, the plurality of tissue engaging elements 140 / 150 are configured to create a friction fixation with the clamped leaflets, and atrial facing apices of the flange 160 are configured to rest on top of the mitral valve or the tricuspid valve, the plurality of tissue engaging elements 164 formed on the flange 160 creating a friction fixation with the wall of the atrium. Although the tissue engaging elements 164, i.e., atrial flange barbs, are oriented upward to exploit back-pressure forces in FIG. 1 A, engagement of the flange barbs may be improved when barbs are oriented more radially or downward. The refined geometry of the tissue engaging elements enhances tissue penetration depth and circumferential fixation at the atrial wall. For example, see FIGS. 12A and 12B showing the atrial tines 267.

[0114] Therefore, multiple fixation mechanisms are provided by the prosthetic implant 100. Even the prosthetic implant 100 lacking the flange 160 is configured to clamp leaflets of the aortic valve between the inner frame 110 and the outer frame 120 in response to deployment of the prosthetic implant 100 at the aortic valve, the plurality of tissue engaging elements 140 / 150 creating a friction fixation with the clamped leaflets to provide multiple fixation mechanisms.

[0115] In some embodiments, a prosthetic heart valve system is provided. The prosthetic heart valve system includes the prosthetic implant 100 and the delivery tube 600. The delivery tube 600 configured to carry the prosthetic implant 100 is specifically designed for sequential releasing of the inner frame 110 and outer frame 120 (and flange 160) out of the delivery tube 600. The prosthetic implant 100 may be configured to naturally open the outer frame 120 acting as anchor arms or mechanically actuate them during positioning and deployment via the delivery tube 600. As described below, the delivery tube 600, having two parts 610, 620, is configured to be separated incrementally to achieve the sequential release of 194938-7152-8601.7065472-001024WOPTthe inner frame 110 and outer frame 120.

[0116] FIG. 5 shows a flow chart illustrating a method 500 for delivering a prosthetic implant to a native heart valve of an individual, in accordance with an embodiment. The method 500 will be described with respect to FIGS. 6A - 7, although it will be appreciated that the method 500 may be implemented for any suitable prosthetic implant without departing from the scope of the disclosure.

[0117] At step S502, the method 500 includes inserting a delivery device / tube 600 (shown in FIGS. 6A-6D) into the target native heart valve, for example the left atrium of the individual where a mitral valve is located. The native heart valve may be tricuspid valve or aortic valve instead of the mitral valve, and the mitral valve is used as an example here. The delivery tube 600 may be a capsule type such that two parts 610, 620 may be separated. The delivery tube 600 may be made of plastic. The delivery tube 600 may be disposable. The delivery tube 600 carries the prosthetic implant 100, the inner frame 110 and the outer frame 120 (and the flange 160) being in a radially constrained configuration within the delivery tube 600.

[0118] Next, at step S504 (and also referring to FIG. 6A), the method 500 includes separating a first part 610 of delivery tube 600 from a second part 620, exposing the prosthetic implant 100 partially at the target native heart valve. Until the first part 610 and the second part 620 are separated by at least a first predetermined distance, the components 110, 120, 160 of the prosthetic implant 100 are still retained in the first part 610 and the second part 620.

[0119] Next, at step S506, the method 500 includes continuing to separate the first part 610 from the second part 620 to be separated by at least the first predetermined distance, releasing the outer frame 120 from the delivery tube 600 (e.g., as shown in FIG. 6B). The released outer frame 120 expands to be close to or in contact with the leaflets of the native heart valve. At this point, the diameter of the expanded outer frame 120 may be anywhere between 22 mm to 45 mm. Other than the expanded outer frame 120, the inner frame 110 and the flange 160 are still partially retained in the first part 610 and the second part 620 of the delivery tube 600. FIG. 6C also illustrates the outer frame 120 released from the delivery tube 600 and expanded from the radially constrained configuration. Here, the expanded outer frame 120 may be in a first expanded configuration. FIG. 6D shows an exemplary configuration of the prosthetic implant 100 of which only the outer frame 120 is released and expanded while the inner frame 110 is still retrained in the delivery tube 600. FIG. 6E shows the prosthetic implant 100 in the same configuration as shown in FIG. 6D, without the delivery tube 600. As shown in FIG. 6E, while the outer frame 120 is in the first expanded configuration, the inner frame 204938-7152-8601.7065472-001024WOPT110 is still in the radially constrained configuration. This clearly shows that the inner frame 110 and the outer frame 120 of the prosthetic implant 100 are configured to be released and expand sequentially out of the delivery tube 600. In FIGS. 6D and 6E, the prosthetic implant 100 does not include the flange 160.

[0120] Next, at step S508, the method 500 includes further separating the first part 610 from the second part 620 to be separated by at least a second predetermined distance that is greater than the first predetermined distance.

[0121] Next, at step S510, the method 500 includes releasing the inner frame 110 from the delivery tube 600 when the first part 610 and the second part 620 are separated by at least the second predetermined distance. Once the inner frame 110 is released, following the releasing and expanding of the outer frame 120, the inner frame 110 that was in the radially constrained configuration in the delivery tube 600, as shown in FIGS. 6D and 6E, is also expanded. At this point, the previously expanded outer frame 120 may move to be closer to or make contact with the expanded inner frame 110 in response to the separation by at least the second predetermined distance. For example, the movement of the expanded outer frame 120 and the expansion of the inner frame 110 may occur simultaneously. In another example, the inner frame 110 that was in the first expanded configuration in step S506 may be in a second expanded configuration at step S510. At this point, the outer frame 120 that was in the first expanded configuration may move towards the expanded inner frame 110 by being switched to the second expanded configuration.

[0122] Although not shown in step S512 of FIG. 5, in some embodiments, step S512 also includes releasing and expanding the flange 160 when the inner frame 110 is released and expanded if the prosthetic implant 100 also includes the flange 160 in addition to the inner frame 110 and the outer frame 120. The flange 160 is attached to the inner frame 110 and they are initially in the radially constrained configuration in the unseparated delivery tube 600. When the first part 610 and the second part 620 are separated by at least the second determined distance, both the inner frame 110 and the flange 160 are released and expand together. Ventricular facing apices of the atrial flange 160 rest on top of the mitral and tricuspid valve annulus. Further, the plurality of tissue engaging elements 164 formed on the flange 160 may create a friction fixation with the wall of the atrium. Once anchors and barbs engage tissue, the system is designed to preferentially resist proximal retraction. The deployment sequence favors downward axial advancement to seat the atrial flange firmly against the annulus and minimize residual gaps. However, in some embodiments, for example when the native heart valve is the aortic valve, the prosthetic implant 100 may not include the flange 160, and therefore, there 214938-7152-8601.7065472-001024WOPTwill be no releasing and expanding of the flange 160 at step S512.

[0123] Next, at step S512, the method 500 includes the released / expanded inner frame 110 causing the clamping action with the previously expanded outer frame 120 that is already in contact with the leaflets of the native heart valve. In some embodiments, when the outer frame 120 in the first expanded configuration is switched to the second expanded configuration, the leaflets will move towards the expanded inner frame 110. At this point, the leaflets are sandwiched between the inner frame 110 and the outer frame 120, as shown in FIG. 7. FIG. 8 also illustrates the clamping mechanism, the native leaflets being sandwiched between the inner frame 110 and the outer frame 120 Further, the plurality of tissue engaging elements 140 and / or 150 may create a friction fixation with the leaflets of the heart valve (mitral, tricuspid, or aortic) in addition to fixation by the clamp action. Furthermore, as shown in FIG. 9, axial clamping is also achieved by the expanded prosthetic implant 100. Referring to the arrows in FIG. 9, at this height, the bend in the flange profile overlaps with the outer frame 120. This creates an interference fit for the leaflets and native annulus as they are sandwiched between the outer frame 120 and the bend in the flange 160, hence creating a good axial clamping and stabilizing the valve from bobbing and having no relative motion between the implant 100 and the native valve. FIG. 10 further illustrates an attachment mechanism that allows flange 160 to the inner frame 110 that creates axial clamping. The arrow points to a portion of the prosthetic implant 100 where the inner frame 100 and the flange 160 are attached. The circles in FIG. 10 illustrate the detailed structure of the portion indicated by the arrow. FIG. 11 illustrates various designs of the flange 160.

[0124] Then, at step S514, the method 500 includes withdrawing the delivery tube 600 from the native heart valve once the prosthetic implant 100 is stably deployed at the target heart valve by various fixation mechanisms mentioned above.

[0125] The above-described method 500 is an exemplary way to deploy the prosthetic implant 100 providing multiple fixation mechanisms. The above-described prosthetic implant 100 provides the clamp action generated by the inner frame 110 and the outer frame 120 coupled via the plurality of connection elements 130 to clamp the leaflets of the heart valve. In some embodiments, the prosthetic implant 100 is configured to naturally open anchor arms of the inner frame 110 and the outer frame 120 or mechanically actuate the anchor arms during positioning and deployment of the prosthetic implant 100. Further, the above-described prosthetic implant 100 provides multiple tissue engaging elements or friction elements 140, 150, 164 as additional fixation mechanisms. Thus, the prosthetic implant 100 and method 500 could improve the fixation to the heart valve. In some embodiments, the tissue engaging 224938-7152-8601.7065472-001024WOPTelements or friction elements 140, 150 on the inner frame 110 are hidden by the outer frame 120 during crimping of the prosthetic implant 100. Further, the tissue engaging elements or friction elements 140, 150 are shaped and / or sized to be equal to or less than a wall thickness of the inner frame 110 to allow the prosthetic implant 100 to load and deploy out of the articulating catheter. In some embodiments, the tissue engaging elements or friction elements 164 on the flange 160 are designed such that they come out tangential to the profile curve, allowing them to even out flat or point inwards during loading inside the delivery catheter, thereby preventing the tissue engaging elements or friction elements 164 from catching the inner lining of the delivery catheter.

[0126] The prosthetic implant 100 can be used to address different aortic, mitral and tricuspid valve diseases. For example, the prosthetic implant 100 may be implanted in both the mitral and tricuspid valves. Use of the prosthetic implant 100 eliminates the need for oversizing or coming in contact with the annulus, helping to prevent any restricting movement to the ventricles. For example, since the left ventricular projection is small, use of the prosthetic implant 100 may help with the left ventricular outflow tract patency. Furthermore, since the right ventricular projection is small and does not contact the septum, there is no risk of a conduction disturbance.9-Anchor Construction - 3-Frame Design

[0127] The above-described prosthetic implant 100 has 6 anchors. According to another embodiment of the disclosure, a prosthetic implant 200 is constructed with three frames including 9 anchors, i.e., 9 circumferential points of contact between an inner frame 210 and an outer frame 220 (also referred to as anchor frame). Referring to FIGS. 12A and 12B, the three frames of the prosthetic implant 200 include the inner frame 210, the outer frame 220, and a flange 260 that overlap each other when crimped. When the prosthetic implant 200 is assembled, all of the inner frame 210, outer frame 220, and flange 260 crimp on top of one another. In some embodiments, the inner frame 210, outer frame 220, and flange 260 crimp on top of one another at a lower portion of the prosthetic implant 200 when the prosthetic implant 200 is in an expanded state. The inner frame 210 provides tissue valve scaffolding support. In some embodiments, there are no portions of the prosthetic implant 200 at which only two of the three frames 210, 220, 260 crimp on top of one another when the prosthetic implant 200 is in an expanded state. The inner frame 210 forms the innermost side of the assembled prosthetic implant 200 and is configured to hold the tissue valve. As depicted in FIG. 12A, the inner frame 210 is linear and extends substantially vertically. In general, the structure of the inner frame 210 is similar to the inner frame 110 discussed above. The inner frame 210 holds the tissue 234938-7152-8601.7065472-001024WOPTvalve when the prosthetic implant 200 is deployed at the anatomical heart valve.

[0128] According to yet another embodiment of the disclosure, the prosthetic implant 200 shown in FIGS. 12A and 12B is configured to be crimped, as shown in FIGS. 13A and 13B. Referring to FIGS. 13A and 13B, when the prosthetic implant 200 is in the crimped state, the inner frame 210 overlaps a portion of the flange 260, a top portion of the flange 260 not overlapping with other frames. In some embodiments, lower ends or bottoms of the inner frame 210 and the flange 260 are aligned, and a lower end or bottom of the outer frame 220 is positioned lower than the lower ends or bottoms of the inner frame 210 and the flange 260. A lower portion of the flange 260 is sandwiched between the inner frame 210 and the outer frame 220. When the prosthetic implant 200 is in the crimped state, all of the inner frame 210, outer frame 220, and flange 260 crimp on top of one another, at a lower portion of the prosthetic implant 200, adding to the crimp profile. At a middle portion of the prosthetic implant 200, only two frames, i.e., the inner frame 210 and the flange 260, crimp on top of one another. The inner frame 210 forms the innermost side of the assembled prosthetic implant 200 and is configured to hold the tissue valve when the prosthetic implant 200 is deployed at the anatomical heart valve.

[0129] The outer frame 220 is generally positioned at a lower portion of the prosthetic implant 200 and forms the outermost side of the lower portion of the prosthetic implant 200. Further, the lower end or bottom of the outer frame 220 is the lowest point or bottom of the prosthetic implant 200. In some embodiments, the lower end of the outer frame 220 is positioned lower than the lower end or bottom of the inner frame 210 in the prosthetic implant 200. Each of 9 anchors of the outer frame 220 is configured to capture one of the leaflets of the aortic, mitral, or tricuspid valve and sits inside the cusp of the native aortic, mitral, or tricuspid valve when the prosthetic implant 200 is deployed at the anatomical heart valve.

[0130] Referring to FIG. 12A, When the prosthetic implant 200 is in the expanded state, the flange 260 includes a lower portion 262 that is generally linear and extends substantially vertically. The flange 260 further includes a middle portion 264 having a first curved section 264a extending from an upper end or tip of the lower portion 262, a middle section 264b extending from the first curved section 264a, and a second curved section 264c extending from the middle section 264b. The first curved section 264a and the second curved section 264c are curved in generally opposite directions, as shown in FIG. 12 A. The middle section 264b, positioned between the first curved section 264a and the second curved section 264c, extends substantially horizontally relative to the lower portion 262 or extends slightly upward from the first curved section 264a toward the second curved section 264c. The flange 260 further 244938-7152-8601.7065472-001024WOPTincludes an upper portion 266 that is generally linear and extends from an upper end or tip of the second curved section 264c. In general, the upper portion 266 extends substantially vertically relative to the middle section 264b. Thus, the lower portion 262 and the upper portion 266 of the flange 260 are generally parallel, as shown in FIG. 12A. The flange 260, including the lower portion 262, middle portion 264, and upper portion 166, creates an interference fit with other frames, i.e., inner frame 210 and outer frame 220.

[0131] The flange 260 may further include tissue engaging element(s), such as a barb, hook or tine. Various types of tissue engaging elements may be included at different portions of the flange 260. For example, the flange 260 includes atrial tines 267 pointing outward near the second curved section 264c. According to a side view in FIG. 12A, the atrial tine 267 extends from the middle section 264b. In some embodiments, the atrial tine 267 points slightly upward relative to the middle section 264b. For example, each atrial tine 267 includes a sharp point configured to pierce into the atrial side of a heart valve when the prosthetic implant 200 is deployed at the anatomical heart valve. In addition to the atrial tines 267, the flange 260 further includes mid body tines 268 generally pointing downward such that the mid body tine 268 overlaps with the lower portion 262 of the flange 260 according to the side view in FIG.12A. In some embodiments, the mid body tine 268 is formed extendingly from a bottom end of the first curved section 264a. In some embodiments, the mid body tine 268 stretches all the way to an outflow of the inner frame 210. According to the 3-frame design of the 9 anchor construction, the prosthetic implant 200’ s height Hl corresponds to a distance between the lower end of the outer frame 220 and the upper end or tip of the upper portion 266 of the flange 260 (or an eyelet 269 of the flange 260). In some embodiments, a gap G1 between the flange (middle section 264b) and an upper end or tip of the outer frame 220 (axial gap between the atrial flange and anchor tips) is 5 or about 5 millimeters (mm). The gap G1 may be from a point where the middle section 264b and the second curved section 264c meet to a point where the tip of the lower portion 262 and the first curved section 264a meet. Reducing the gap G1 to less than 5 mm, to approximately 2 mm or less, or even 0 would increase clamping force, prevent flange lift under systolic back pressure, and improve resistance to perivalvular leakage.9-Anchor Construction - Two-Frame Overlapping for Lower Profile

[0132] Referring to FIGS. 14A-14C, according to yet another embodiment of the disclosure, a prosthetic implant 400 is constructed with three frames including 9 anchors, i.e., 9 circumferential points of contact between a tissue scaffold frame 410 and an outer frame 420 (also referred to as anchor frame). The three frames include the tissue scaffold frame 410, the outer frame 420, and a flange 460. The prosthetic implant 400 is constructed such that a bottom 254938-7152-8601.7065472-001024WOPTof the prosthetic implant 400 corresponds to a bottom of the outer frame 420 and a top of the prosthetic implant 400 corresponds to an upper end or tip of the flange 460. The prosthetic implant 400’ s height H2 corresponds to a distance between the lower end of the anchor frame 420 and the upper end or tip of the flange 460 where an eyelet 468 is formed. Although three frames 410, 420, 460 are provided in the prosthetic implant 400, only two-frame overlapping is present. That is, in general, three-frame overlapping is absent in the prosthetic implant 400 and only two of the three frames 410, 420, 460 crimp on top of one another, as shown in FIG.14C. This configuration, providing two-frame overlapping at any axial position, decreases the device profile by reducing the folded diameter and improving catheter compatibility. Reducing stacked frame overlapping supports smaller delivery catheter diameters. Profile reduction directly impacts procedural ease, vascular compatibility, and clinical adoption.

[0133] Although the inner frame and the outer frame were used to describe interference fit in the previously described embodiments, in the present embodiment, the outer frame 420 starts smaller than the flange frame 460 which behaves like the previously described inner frame creating the interference fit. In the present embodiment, the flange 460 acts like an inner frame on which the outer frame 420 squeezes to create the interference fit. The flange 460 may not have an enough height to enable attachment of a tissue valve, and hence the tissue scaffold frame 410 is added to act as a scaffold that provides a height for tissue valve attachment. Thus, the tissue scaffold frame 410 is distinguished from the inner frame 110, 210 described above in that the tissue scaffold frame 410 has a different function.

[0134] First two-frame overlapping - The tissue scaffold frame 410 overlaps a portion of the flange 460 always being above the outer frame 420, thereby preventing overlap and three frame stack up. Thus, in the crimped state form, only two of the three frames 410, 420, 460 stay crimped on top of one another throughout the axial length of the crimped prosthetic implant 400, i.e., the tissue scaffold frame 410 and the flange 460 crimp on top of one another, and the flange 460 and the outer frame 420 crimp on top of one another. However, the tissue scaffold frame 410 and the outer frame 420 do not overlap. This design helps reducing the crimp profile.

[0135] Second two-frame overlapping - The outer frame 420 overlaps the lower portion of the flange 460 such that mostly only two frames, i.e., the outer frame 420 and the flange 460, crimp on top of one another at the lower portion of the prosthetic implant 400. In some embodiments, a lower end or bottom of the outer frame 420 is positioned lower than lower ends or bottoms of the inner frame 410 and the flange 460. In some embodiments, the prosthetic implant 400 includes only a small portion where all of the inner frame 410, the outer frame 420264938-7152-8601.7065472-001024WOPTand the flange 460 overlap, near the tip of the outer frame 420 and near the bottom of the inner frame 410. In this embodiment, the inner frame 410 and the flange 460 together make the stent structure for tissue valve attachment. Further, for the prosthetic implant 400, a gap G2 between the tip of the outer frame 420 and a generally horizontal middle portion of the flange 460, which is similar to the middle section 264b of the flange 260 in the prosthetic implant 200, is less than the gap G1 of the prosthetic implant 200 discussed above, thus, reducing the crimp profile of the prosthetic implant 400, compared to the crimp profile of the prosthetic implant 200. For example, the gap G2 of the prosthetic implant 400 is 2 or about 2 mm.9-Anchor Construction with Two Frames Attached Using Suture - Lower Profile

[0136] Referring to FIGS.15A-15C, a tissue scaffolding frame 510 is attached to a flange frame 560 which behaves like the inner frame in the previously described embodiments, using sutures 580 to prevent separation and rotation between the two frames 510 and 560. In FIGS. 15A-15C, the outer frame of the prosthetic implant 500 is omitted. In some embodiments, the tissue scaffolding frame 510 has features that enable easier attachment. The outer frame (not shown in the drawings) sits below the tissue scaffolding frame 510 with no overlap with the tissue scaffolding frame 510, thereby always preventing three frame stack up. Referring to FIG. 15D, according to another embodiment of the disclosure, instead of the tissue scaffolding frame 510 shown in FIGS. 15A-15C, a shorter tissue scaffolding frame 511 is used. For example, the tissue scaffolding frame 511 has 18 cells. Therefore, the crimp profile is reduced from Pl shown in FIG. 15A to P2 as shown in FIG. 15D.Foam-Based Sealing Structures

[0137] Referring to FIGS. 16A-16C, according to yet another embodiment of the disclosure, a prosthetic implant 600 is constructed with at least two frames, including an inner frame 630 and a flange 660. Although not shown in the drawings, an optional outer / anchor frame may also be included in the prosthetic implant 600. In this embodiment, foam-based sealing structures, such as porous foam skirt, may be attached to a portion of the prosthetic implant 600. In some embodiments, the sealing structures include sponge or felt cloth. In one embodiment, a sealing element is an open-cell reticulated polyurethane foam. In some embodiments, a sealing element is open-cell or closed foam variants. The foam-based sealing structure(s) may be positioned at one or multiple axial locations on the valve, as exemplified in FIG. 17, and serves multiple purposes: (i) filling irregular gaps between native anatomy and the valve frame, (ii) increasing effective surface area for tissue ingrowth, and (iii) supporting long-term biological healing and sealing.

[0138] As exemplified in FIG. 16A, a foam skirt (labeled as “Foam” in the drawing)274938-7152-8601.7065472-001024WOPTmay be attached such that the foam contacts a portion of the flange 660, in particular, the bottom side of a middle portion and a first curved section extending from an upper end of a lower portion of the flange 660. As exemplified in FIG. 16B, a foam skirt (labeled as “Foam” in the drawing) may be attached to surround a part of an upper portion and a second curved section of the flange 660. The portions and curved sections of the flange 660 are the same as or similar to those of the flange 260 described above, referring to FIG. 12 A. As exemplified in FIG. 16C, a foam skirt (labeled as “Foam” in the drawing) may be attached to each or some of a plurality of lower flange elements forming a cylindrical structure at a lower portion of the prosthetic implant 600.Helical Ring Based Sealing Structure

[0139] Referring to FIGS. 18A-18D, according to yet another embodiment of the disclosure, a helical ring 190 is shaped with repeating elements of a spring element 192 to form a toroidal geometry. The spring element 192 is covered by a cover 194 such as a thin, porous cloth, bonded polymer, electro spun member or any other suitable layer to form a torus. This torus structure can undergo compression and is axially and radially compliant. The 3D spring elements 192 behave like a 3D Z-stent (self-expanding, stainless steel wire stent designed for structural support in tubular structure) which allows for easier crimping. The torus structure of the helical ring 190 also exhibits high compressibility. When a prosthetic implant 1800 shown in FIG. 18C is deployed to the native heart valve, the helical ring 190 is configured to be placed on the ventricular side of the atrial flange 1860. The 3D spring elements 192 is attached to the atrial flange 1860 at 2 points 1862 and 1864 per turn, allowing for axial and radial movement during crimping and post valve deployment. In some embodiments, the spring elements 192 is attached to 2 (1862, 1864) or more points of the atrial flange 1860 per turn, allowing for elongation and flattening during device crimping, allowing for reduced crimp profile. Further, each coil or loop 190a, 190b, ... 190n of the helical ring 190 is inclined or angled, as exemplified in FIG. 18C, to elongate the spring element 192 using strut anchor points during loading onto the delivery catheter. Since the spring element 192 is sideways biased, it is soft and configured to radially conform easily while also extending easily into any gaps. Due to the elastic nature of the sealing, the helical ring 190 based sealing structure may have benefits over the foam described above because the helical ring 190 can be dynamic and gradually expand over time. The prosthetic implant 1800 shown in FIG. 18C also includes an inner frame 1810 and an outer frame 1820. FIG. 18D shows the front / side view of the prosthetic implant 1800 shown in FIG. 18C. The low profile compressible ring 190 is configured to act as a sealing member to stop paravalvular leaks, the profile being even lower than the profile of the 284938-7152-8601.7065472-001024WOPTcompressible foam discussed above. The helical toroidal shape of the ring 190 creates a zig zag pattern in 3 dimension, allowing the spring element / wire 192 to radially and axially crimp unlike a wire braid that stays in one plane and locks up on crimping, preventing a lower profile. The compression of the ring 190 against native annulus / native leaflets creates better sealing.Anchor Geometry to Increase Surface Area for Interference Fit

[0140] FIGS. 19A-19C illustrate various types of stent anchors having different shapes of anchor tips. As described above, the outer frames of the prosthetic implant function as anchors. For example, FIG. 19A shows a triangle-shaped anchor tip, FIG. 19B shows an M-shaped anchor tip, and FIG. 19C shows a roof style anchor tip. As shown in FIGS. 19A and 19B, the widths W1 and W2, respectively, of the anchor tips that are in a crimped state are different, W2 being greater than Wl. When the stent anchors are expanded, W1 and W2 increase to W1+ and W2+, respectively, W2+ being greater than W1+. Furthermore, the space between two anchor tips is smaller in FIG. 19B than in FIG. 19A due to the increased width W2+ of the M-shaped anchor tip. Although the width of the roof style anchor tips shown in FIG. 19C is not compared with Wl and W2 shown in FIGS. 19A and 19B, it can be seen that the space between two anchor tips is mostly at the top portion of the stent anchor in FIG. 19C. In contrast, the space between two anchor tips extends between the bottom and the top of the stent anchors in FIGS. 19A and 19B.

[0141] FIG 20B illustrates an exemplary prosthetic implant 2000 including an outer frame 2020 that functions as an anchor, flange 2060, and an inner frame (not shown). FIG 20A illustrates the outer frame 2020 that is covered with echogenic material that could be polymer, fabric, suture, membrane, suture dopped with compounds, denser metal, and / or metal coating that enhance radiopacity or echogenicity of the outer prosthetic implant 2000.

[0142] FIG. 20B illustrates an exemplary prosthetic implant 2000 including an outer frame 2020 that functions as an anchor, a flange 2060, and an inner frame (not shown). FIG.20A illustrates the outer frame 2020. As indicated by triangles in broken lines in FIGS. 20A and 20B, a space is formed between the anchor tips 2022. The space between the anchor tips 2022 is where the native leaflets are not pinched or supported, and thus, the native leaflets may be free to move, resulting in not being captured by the outer frame 2020 and the inner frame.

[0143] FIGS. 21A-21C illustrate various types of anchor tips corresponding to the anchor tips shown in FIGS. 19A-19C, respectively. In FIGS. 21 A-21C, portions of native heart valve leaflets are shown in spaces formed between the two anchor tips. Those portions of the native heart valve leaflets shown in FIGS. 21 A-21C are not captured / pinched / supported by the frames of the prosthetic implants. It is noted that the sizes of the portions of the native heart 294938-7152-8601.7065472-001024WOPTvalve leaflets shown in FIGS. 21A-21C are different based on the size of the space formed between two anchor tips.

[0144] Referring to FIGS. 19A-21C, according to yet another embodiment of the disclosure, depending on the outer frame (stent anchor) geometry, i.e., a shape and a size of the anchor tip, the sizes and shapes of the spaces formed between two anchor tips are different. For example, referring to FIG. 2 IB, the outer frame is shaped in the form of “M,” allowing the outer frame (anchor) to crimp and keep the tip smaller, also allowing the outer frame to navigate successfully through the native chordal structure. Once the prosthetic valve implant is released from the delivery system catheter, this outer frame design allows for a larger surface area once expanded, thus providing more support to capture native leaflets and chords. By designing the anchor tips as exemplified in FIGS. 21B and 21C, a larger surface area is available for the outer frame / anchor to capture wider / more areas of the native leaflet and chords.Flange Eyelets and Valve Attachment to the Delivery Tube / Catheter

[0145] FIG. 22A illustrates frames of a prosthetic implant, the frames including an outer frame 2220 and a flange 2260. FIG. 22B illustrates the flange 2260 with a plurality of eyelets 2268. Referring to FIGS. 22A-22B, according to yet another embodiment of the disclosure, a plurality of eyelets 2268 are formed at the top of the flange 2260. As illustrated in FIG. 22A, according to an embodiment, the helix pitch (vertical distance) between two consecutive eyelets 2268 increases gradually in one direction. The eyelets 2268 according to the present embodiment are different from the eyelets shown in the previously described embodiments, for example, the eyelets 168 shown in FIG. 1A, in that the eyelets 2268 are rotated or twisted 90 degrees, compared to the eyelets 168 shown in FIG. 1 A. Also referring to FIG. 22C, the twisted or rotated eyelets 2268 on a flange inflow are configured to engage with a delivery tube or a delivery catheter such as the one exemplified in FIGS 6A-6B. For example, the exemplary delivery tube shown in FIG. 22C includes a nose cone 2272, an outflow helix 2274, a nose cone lumen 2276, an inflow helix 2278, and an inflow cable 2280. Since there are only two lumens 2276, 2280, a low profile is allowed by reducing a number of lumens on which the valve crimps. Two lumens allow for implant repositioning such that the valve in its crimped state sits only on the nose cone lumen 2276, allowing crimping to a smaller crimp profile. The rigid inflow helix 2278, which engages with the twisted eyelets 2268, minimizes stretching while loading onto the delivery tube, also allowing secure release during deployment of the implant out of the delivery tube.

[0146] FIGS. 23A-23C illustrate double eyelets of an atrial flange, according to an embodiment of the disclosure. A flange 2360 has double eyelets 2368 that are arranged 304938-7152-8601.7065472-001024WOPTvertically. A suture loop 2370 is formed through the double eyelets 2368 on one side of the flange 2360 and suture knots 2372 are formed on the other side of the flange 2360, as shown in FIG. 23C. The design of the double eyelets 2368 allows the flange 2360 to be attached to the delivery system while minimizing impact to the prosthetic implant’s crimp length.

[0147] FIGS. 24A-24F illustrate windows on the atrial flange outflow of the flange 2460. Referring to FIG. 24A, the flange outflow has a series of alternating dual windows and single windows Wl. The outer frame 2420 has a series of dual windows W2, W3. Therefore, the dual windows W2, W3 of the outer frame 2420 overlap the dual windows and single windows Wl of the flange 2460 alternately, as shown in the box of FIG. 24A. Referring to FIG.24B, the bridge distance B of the single window Wl of the flange 2460 shown between the arrows is equal to or greater than the bridge distance A between the anchor windows W2, W3, i.e., between the arrows. When the overlapping outer frame 2420 and the flange 2460 are connected using a coupler 2480 such as cloth, wire, suture or C clip retainer or any other suitable mechanism, as shown in FIG. 24C, this creates a pseudo pin joint or revolute joint that allows the outer frame 2420 to behave like a fulcrum when mechanically actuated by a delivery catheter, as shown in FIG. 24E. FIG. 24C shows three different configurations of coupling between the outer frame 2420 and the flange 2460 with the coupler 2480, a different fulcrum point created according to the different configuration of coupling. Although all three configurations may be implemented according to various embodiments, in a preferred embodiment, the coupling configuration is as shown on the right side in FIG. 24C such that no portion of the flange 2460 overlaps the window W3 of the outer frame 2420 or the bottom edge of the bridge of the flange 2460, having the bridge distance B, overlaps the bridge of the outer frame 2420 having the bridge distance A. An exemplary pseudo pin joint created by the frame geometry is shown in FIG. 24F.

[0148] In general, the following three primary anchoring mechanisms form the basis of valve fixation for the above-described prosthetic implants: i) atrial flange fixation: an expandable flange positioned supra-annularly for axial positioning and fixation against the atrial wall or annulus, incorporating barbs or tines for tissue engagement; ii) friction / interference anchoring: anchors and an inner frame cooperate to capture native valve leaflets and chordae via friction fit; and iii) axial clamping: compression generated between the atrial flange and anchor tips produces circumferential tissue pinching that resists axial displacement and fluid leakage. These three mechanisms function cooperatively and remain invariant across design iterations.

[0149] As discussed above, increasing anchor count reduces circumferential gaps 314938-7152-8601.7065472-001024WOPTbetween adjacent anchors, thereby increasing tissue capture area and improving tissue capture. This directly improves sealing below the annulus and reduces risk of paravalvular leak. The 9-anchor configuration preserves the same anchoring mechanics while optimizing surface engagement. The 9-anchor configuration of the prosthetic implant described above generally allows increased ventricular anchoring and paravalvular reduction, i.e., reduced paravalvular leak risk, compared to the 6-anchor configuration described earlier. In particular, the crimp profile is reduced for the 9-anchor configuration because the flange is able to crimp to a smaller diameter, as the number of points is reduced from 24 of the 6-anchor configuration to 18 of the 9-anchor configuration. As described above, a prosthetic implant may have 6, 9, or 12 or any other number of attachment points between an inner frame and an outer frame. In general, valve attachment would become easier and more uniform for a prosthetic implant having 9 attachment points than a prosthetic implant having 12 attachment points. Moreover, overall device profile can be reduced by limiting frame overlapping to no more than two frames at any axial point. The reduction in the device profile can support smaller delivery catheter sizes.

[0150] To inventors’ knowledge, there are no prosthetic heart valves constructed by a friction fit, an interference fit or press fit. The inventive prosthetic implant is considered to be the first prosthetic heart valve constructed by the friction fit by j oining two frames. The surfaces of the joined frames are in close contact, and the friction between them is sufficient to hold them together without the need for adhesives, fasteners, or other mechanical means. Further, when the prosthetic implant is delivered from a delivery device and deployed at the native heart valve, the friction force is converted to a clamping force provided by expanded frames to clamp portions of the native heart valves, such as leaflets, between them.

[0151] The disclosed device, system and method provide a unique advantage over existing solutions by allowing for safe and effective implanting of the prosthetic heart valve. Compared to existing solutions, the disclosed device, system and method provide multiple fixation mechanisms by not only catching the native leaflets or subvalvular apparatus (primary fixation) but also providing barbs to create fiction by digging into the native tissues (secondary fixation) which can be implemented on any of the frames. Additionally, the disclosed device, system and method can be used to replace a wide range of aortic, mitral and tricuspid valve anatomies with minimal screen-failure rate.

[0152] Furthermore, the disclosed device, system and method offer a very easy way of implanting the prosthetic heart valve. This provides a range of options for physicians to choose from depending on the patient's unique situation. Overall, the disclosed device, system and method improve upon existing solutions by providing a safe, effective, and flexible solution 324938-7152-8601.7065472-001024WQPTthat potentially improves patient outcomes and quality of life.

[0153] One of ordinary skill in the art would readily recognize that the method described above could involve other additional steps, which are not described in detail here. These additional steps include, but are not limited to, anesthesia, sterilization, heparinization, accessing the patient’s heart via various routes such as femoral, transseptal, transaortic and transapical approaches, ventricular pacing, stitching of the access site or percutaneous femoral closure. For example, more information on these procedures are described in Ye et al. (Transapical aortic valve implantation in humans. Ye J, Cheung A, Lichtenstein SV, Carere RG, Thompson CR, Pasupati S, Webb JG. J Thorac Cardiovasc Surg. 2006 May; 131(5): 1194-6), Lichtenstein et al. (Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Lichtenstein SV, Cheung A, Ye J, Thompson CR, Carere RG, Pasupati S, Webb JG. Circulation. 2006 Aug 8; 114 (6):591-6. Epub 2006 Jul 31), Kurra et al. (Preprocedural imaging of aortic root orientation and dimensions: comparison between X-ray angiographic planar imaging and 3-dimensional multidetector row computed tomography. Kurra V, Kapadia SR, Tuzcu EM, Halliburton SS, Svensson L, Roselli EE, Schoenhagen P. JACC Cardiovasc Interv. 2010 Jan;3 (1): 105-13.), Wake et al. (Computed tomography angiography for transcatheter aortic valve replacement. Wake N, Kumamaru K, Prior R, Rybicki FJ, Steigner ML. Radiol Technol. 2013 Mar-Apr;84(4):326-40.), and Little et al. (Multimodality noninvasive imaging for transcatheter aortic valve implantation: a primer. Little SH, Shah DJ, Mahmarian JJ. Methodist Debakey Cardiovasc J. 2012 Apr-Jun;8(2):29-37.), all of which are incorporated by reference herein in their entirety as fully set forth.

[0154] The various methods and techniques described above provide a number of ways to carry out the application. Of course, it is to be understood that not necessarily all objectives or advantages described can be achieved in accordance with any particular embodiment described herein. Thus, for example, those skilled in the art will recognize that the methods can be performed in a manner that achieves or optimizes one advantage or group of advantages as taught herein without necessarily achieving other objectives or advantages as taught or suggested herein. A variety of alternatives are mentioned herein. It is to be understood that some preferred embodiments specifically include one, another, or several features, while others specifically exclude one, another, or several features, while still others mitigate a particular feature by inclusion of one, another, or several advantageous features.

[0155] Furthermore, the skilled artisan will recognize the applicability of various features from different embodiments. Similarly, the various elements, features and steps discussed above, as well as other known equivalents for each such element, feature or step, can 334938-7152-8601.7065472-001024WOPTbe employed in various combinations by one of ordinary skill in this art to perform methods in accordance with the principles described herein. Among the various elements, features, and steps some will be specifically included and others specifically excluded in diverse embodiments.

[0156] Although the application has been disclosed in the context of certain embodiments and examples, it will be understood by those skilled in the art that the embodiments of the application extend beyond the specifically disclosed embodiments to other alternative embodiments and / or uses and modifications and equivalents thereof.

[0157] In some embodiments, the terms “a” and “an” and “the” and similar references used in the context of describing a particular embodiment of the application (especially in the context of certain of the following claims) can be construed to cover both the singular and the plural. The recitation of ranges of values herein is merely intended to serve as a shorthand method of referring individually to each separate value falling within the range. Unless otherwise indicated herein, each individual value is incorporated into the specification as if it were individually recited herein. All methods described herein can be performed in any suitable order unless otherwise indicated herein or otherwise clearly contradicted by context. The use of any and all examples, or exemplary language (for example, “such as”) provided with respect to certain embodiments herein is intended merely to better illuminate the application and does not pose a limitation on the scope of the application otherwise claimed. No language in the specification should be construed as indicating any non-claimed element essential to the practice of the application.

[0158] Preferred embodiments of this application are described herein, including the best mode known to the inventors for carrying out the application. Variations on those preferred embodiments will become apparent to those of ordinary skill in the art upon reading the foregoing description. It is contemplated that skilled artisans can employ such variations as appropriate, and the application can be practiced otherwise than specifically described herein. Accordingly, many embodiments of this application include all modifications and equivalents of the subject matter recited in the claims appended hereto as permitted by applicable law. Moreover, any combination of the above-described elements in all possible variations thereof is encompassed by the application unless otherwise indicated herein or otherwise clearly contradicted by context.

[0159] All patents, patent applications, publications of patent applications, and other material, such as articles, books, specifications, publications, documents, things, and / or the like, referenced herein are hereby incorporated herein by this reference in their entirety for all 344938-7152-8601.7065472-001024WOPTpurposes, excepting any prosecution file history associated with same, any of same that is inconsistent with or in conflict with the present document, or any of same that may have a limiting affect as to the broadest scope of the claims now or later associated with the present document. By way of example, should there be any inconsistency or conflict between the description, definition, and / or the use of a term associated with any of the incorporated material and that associated with the present document, the description, definition, and / or the use of the term in the present document shall prevail.

[0160] It is to be understood that the embodiments of the application disclosed herein are illustrative of the principles of the embodiments of the application. Other modifications that can be employed can be within the scope of the application. Thus, by way of example, but not of limitation, alternative configurations of the embodiments of the application can be utilized in accordance with the teachings herein. Accordingly, embodiments of the present application are not limited to that precisely as shown and described.354938-7152-8601.7065472-001024WOPT

Claims

WHAT IS CLAIMED IS:

1. A prosthetic implant comprising:an inner frame; andan outer frame,wherein the prosthetic implant is assembled by a friction fit or an interference fit, allowing for clamping native leaflets and / or sub valvular apparatus between the inner frame and the outer frame, andwherein the friction fit is achieved by the outer frame being smaller than the inner frame or the outer frame and the inner frame being the same size, the inner frame and the outer frame assembled to the prosthetic implant by forcing the inner frame into the outer frame.

2. The prosthetic implant of claim 1, wherein a tapered geometry of tips of the outer frame allows passage of the outer frame through the sub valvular apparatus, and the tips of the outer frame are configured to aid capturing of the native leaflets.

3. The prosthetic implant of any one of claims 1-2, wherein friction elements emerging from the inner frame are hidden by the outer frame while the prosthetic implant is in a crimped or constrained configuration, allowing seamless loading of the prosthetic implant inside a catheter.

4. The prosthetic implant of claim 3, wherein the friction elements allow for increased resistance to secure the native leaflets in between the inner frame and the outer frame, preventing the clamped native leaflets from sliding out.

5. The prosthetic implant of any one of claims 1-4, further comprising a flange, wherein axial clamping is achieved by attaching the flange to the inner frame that axially overlaps tips of the outer frame.

6. The prosthetic implant of claim 5, wherein bends in the flange are configured to stay at or below the tips of the outer frame.364938-7152-8601.7065472-001024WQPT7. The prosthetic implant of claim 5, wherein an axial interference fit in between the flange and the inner frame is configured to provide intra annular sealing.

8. The prosthetic implant of claim 5, wherein friction elements are provided on the flange, the friction elements on the flange providing secondary fixation, preventing axial atrial motion of the prosthetic implant and securing the prosthetic implant supra-annular.

9. The prosthetic implant of any one of claims 1-8, wherein the prosthetic implant is configured to enable valve under-sizing to the native anatomy-annuli and the ventricles.

10. The prosthetic implant of any one of claims 1-8, wherein a clamping force is enhanced at the tip of the outer frame by changing a profile and / or shape of the inner frame and the outer frame.

11. The prosthetic implant of any one of claims 1-8, wherein the flange is curved inwards on the atrial side, making atrial tips of the flange atraumatic, eliminating a risk of abrasion of the native atrial tissue.

12. A method for assembling the prosthetic implant of any one of claims 1-11, the method comprising expanding the outer frame beyond a set diameter to create pre-tension in the outer frame made of metal or nitinol introducing residual pre-stresses, thereby making the outer frame more crack resistant and improving fatigue life of the prosthetic implant.

13. A prosthetic implant for a prosthetic heart valve, the prosthetic implant comprising:an inner frame housing a plurality of prosthetic leaflets;an outer frame with a size that is equal to or smaller than the inner frame prior to valve assembly such that post assembly the inner frame stretches the outer frame, causing an inner diameter of the outer frame to be equal to an outer diameter of the inner frame, thereby reaching equilibrium and causing a tight interference fit in between the inner frame and the outer frame; anda plurality of connection points attaching the inner frame with the outer frame, the inner frame and the outer frame joined at each connection point of the plurality of connecting points.374938-7152-8601.7065472-001024WOPT14. The prosthetic implant of claim 13, wherein the outer frame and the inner frame are the same size, and wherein the prosthetic implant further comprises a soft component including suture or cloth on the outer surface of the inner frame or on the inner surface of the outer frame, the soft component causing increased interference between the inner frame and the outer frame.

15. The prosthetic implant of claim 13, further comprisinga flange, a diameter of the flange being changeable from a size that is same as or similar to the outer diameter of the inner frame to a larger diameter to provide intra-annular and supraannular sealing,wherein:the flange is attached to the inner frame; orthe flange is a part of the inner frame.

16. The prosthetic implant of claim 15, wherein the flange and the outer frame are configured to sit on an outer wall of the inner frame, with an axial overlap.

17. The prosthetic implant of claim 15, wherein the flange has a plurality of friction elements including tines, hooks or barbs which penetrate into the native tissue / anatomy.

18. The prosthetic implant of any one of claims 14-17, wherein an original outer diameter of the inner frame is greater than an original inner diameter of the outer frame by about 1-10 millimeter (mm), prior to the outer frame receiving the inner frame for assembly of the prosthetic implant.

19. The prosthetic implant of any one of claims 14-18, wherein (a) the outer frame stretches to receive within the inner frame, (b) the inner frame shrinks for the outer frame to receive within the inner frame, or (c) the outer frame stretches and the inner frame shrinks for the outer frame to receive within the inner frame, the outer frame being in direct contact with the inner frame.

20. The prosthetic implant of claim 19, wherein the stretching of the outer frame induces tensile pre-strain in the outer frame made of metal during the assembly procedure and results in compressive residual stresses, the compressive residual stresses combined with tensile cyclic loading resulting in enhanced fatigue life and crack resistance of the outer frame.384938-7152-8601.7065472-001024WOPT21. The prosthetic implant of claim 18, wherein the inner frame and the outer frame of the assembled prosthetic implant generate a clamping force between the inner frame and the outer frame, securing leaflets of the anatomical heart valve between the inner frame and the outer frame in response to deployment of the prosthetic implant at the anatomical heart valve.

22. The prosthetic implant of claim 21, wherein the secured native leaflets between the inner frame and the outer frame allow for under-sizing the prosthetic implant to the native annulus.

23. The prosthetic implant of any one of claims 14-22, wherein the prosthetic implant is configured to create a pseudo pin joint or revolute joint between two frames, the pseudo pin joint or revolute joint being configure to mechanically actuate one of the two frames during positioning and deployment of the prosthetic implant via a delivery catheter tube.

24. The prosthetic implant of 23, wherein the anchor arms are covered with sutures, fabric or membranes and / or additional denser metal to enhance device echogenicity.

25. The prosthetic implant of claim 21, wherein:the outer frame is shaped such that the inner diameter of the outer frame decreases gradually as the outer frame moves away from the connection points to the inner frame, in order to increase the clamping force away from the connection points of the inner and outer frame to one another.

26. The prosthetic implant of claim 21, wherein the inner frame is shaped such that the inner diameter of the inner frame increases as the inner frame moves away from the connection points to the outer frame, in order to enhance the interference fit and the clamping force to secure the native leaflets and / or sub valvular apparatus in between the inner frame and the outer frame.

27. The prosthetic implant of claim 25, wherein the inner diameter at top of the outer frame is greater than the inner diameter at bottom of the outer frame by about 1-3 mm.394938-7152-8601.7065472-001024WQPT28. The prosthetic implant of any one of claims 14-27, wherein the outer frame is generally cylindrical, the inner diameter of the outer frame being generally consistent from a bottom end to a top end of the outer frame.

29. The prosthetic implant of any one of claims 14-28, wherein the inner frame is generally cylindrical such that the inner diameter of the inner frame is generally consistent from a bottom end to a top end of the inner frame.

30. The prosthetic implant of any one of claims 14-29, wherein the original outer diameter of the inner frame is in a range of about 22 mm to about 35 mm, and the original inner diameter of the outer frame is in a range of about 20 mm to about 31 mm, prior to the outer frame receiving the inner frame.

31. The prosthetic implant of any one of claims 14-30, wherein a height of the inner frame is greater than a height of the outer frame, the entire height of the outer frame overlapping a portion of the height of the inner frame.

32. A prosthetic implant for a heart valve, the prosthetic implant comprising:an inner frame configured for flexible attachment around an anatomical heart valve, the inner frame housing bioprosthetic or polymeric leaflets;an outer frame flexibly surrounding the inner layer, the outer layer being conformable to change a size of an inner diameter of the outer frame in response to changes of a size of an outer diameter of the inner frame, the inner diameter of the outer frame changing between a first diameter and a second diameter, the first diameter being greater than the second diameter, the size of the outer diameter of the inner frame being initially greater than the size of the inner diameter of the outer frame to cause a clamping force to the anatomical heart valve; and a plurality of connection elements, each connection element of the plurality of connection elements providing an attachment point at which the inner frame and the outer frame are joined such that at least portions of the anatomical heart valve are sandwiched between the joined inner frame and outer frame in response to the clamping force.

33. The prosthetic implant of claim 32, wherein the outer frame has a plurality of tips, each of which is configured to be behind the native leaflets and function as clamping elements, and each clamping element is configured to capture at least part of the native leaflets of the 404938-7152-8601.7065472-001024WQPTanatomical heart valve in response to deployment of the prosthetic implant into the anatomical heart valve.

34. The prosthetic implant of any one of claims 32-33, wherein the anatomical heart valve is a mitral valve or a tricuspid valve, and the prosthetic implant has 2, 3, 4, 6, 9, or 12 attachment points between the inner frame and the outer frame.

35. A prosthetic implant for a heart valve, the prosthetic implant comprising:an inner frame having an inner-receiving space housing the bioprosthetic or prosthetic leaflets;an outer frame flexibly surrounding the inner frame, the outer frame being conformable to change a size of an inner diameter of the outer frame in response to changes of a size of an inner diameter of the inner frame, the size of the inner diameter of the inner frame being initially greater than the size of the inner diameter of the outer frame prior to assembly of the prosthetic implant by stretching the outer frame and / or shrinking the inner frame to cause a clamping force between the first frame and the outer frame; anda plurality of friction elements including barbs, hooks, or tines, the fiction elements being configured on the inner frame and hidden by the outer frame, the plurality of friction elements creating a friction fixation when the anatomical heart valve is received within the inner-receiving space.

36. The prosthetic implant of claim 35, further comprising a flange arranged around the inner frame, the flange being configured to engage a wall of an atrium in response to deployment of the prosthetic implant at the anatomical heart valve.

37. The prosthetic implant of claim 36, wherein the atrial flange and the outer frame are attached to the inner frame while the outer frame and flange overlap in height in order to create axial clamping of the native tissue.

38. The prosthetic implant of claim 36, wherein the anatomical heart valve is a mitral valve or a tricuspid valve.

39. The prosthetic implant of claim 38, further comprising a plurality of friction elements including barbs, tines, or hooks, the friction elements being formed on or attached to an outer 414938-7152-8601.7065472-001024WQPTsurface of the flange, the plurality of friction elements formed on the flange creating a friction fixation with the wall of the atrium or the native tissue.

40. The prosthetic implant of claim 39, wherein:the hidden friction elements configured on the inner frame allows smooth loading inside a delivery system catheter; and / orthe friction elements formed on the flange are configured to rest on a curved section of a profile of the prosthetic implant; and automatically straighten and hide inside the delivery system catheter during device crimping and loading.

41. The prosthetic implant of claim 39, wherein the prosthetic implant is configured to clamp leaflets of the mitral valve or the tricuspid valve between the inner frame and the outer frame in response to deployment of the prosthetic implant at the mitral valve or the tricuspid valve.

42. The prosthetic implant of claim 41, wherein the plurality of friction elements formed on or attached to the outer surface of the flange are configured to create a friction fixation with the clamped leaflets.

43. A method for deploying a prosthetic implant within an anatomical heart valve, the method comprising:inserting a delivery device into a patient to access the patient’ s heart, the delivery device carrying the prosthetic implant of any one of claims 1-42, the inner frame and the outer frame being in a radially constrained configuration within the delivery device;advancing the delivery device to the anatomical heart valve; anddeploying the prosthetic implant at the anatomical heart valve by releasing the inner frame and the outer frame sequentially in response to stepwise separation of a head part of the delivery device from a body part of the delivery device such that the radially constrained outer frame is released and radially expanded, and then, the radially constrained inner frame is released and radially expanded,wherein leaflets of the anatomical heart valve are clamped between the radially expanded outer frame and inner frame of the deployed prosthetic implant.424938-7152-8601.7065472-001024WQPT44. The method of claim 43, further comprising deploying the atrial flange with an overlap in height with the outer frame, axially clamping the native leaflets caused by the interference fit between the flange and the outer frame.

45. A prosthetic implant for a prosthetic heart valve, the prosthetic implant comprising:an inner frame housing a plurality of prosthetic leaflets;an outer frame that is smaller than the inner frame prior to valve assembly such that post assembly a diameter of the inner frame is slightly reduced by squeezing of the outer frame; anda plurality of connection points attaching the inner frame with the outer frame, the inner frame and the outer frame joined at each connection point of the plurality of connecting points.

46. The prosthetic implant of claim 45, further comprising a flange that (a) is attached to the inner frame, (b) is part of the inner frame, or (c) includes a part of the outer frame, wherein a diameter of the flange is changeable from a first size that is approximately the same as the outer diameter of the inner frame to a second size that is a larger than the outer diameter of the inner frame, the diameter of the flange sealing an intra-annular and supra-annular space.

47. The prosthetic implant of claim 46, wherein the flange is a part of the inner frame, the inner frame including the flange and a separate ring of frame attached to the flange at an area where the flange starts increasing in diameter.

48. The prosthetic implant of claim 47, wherein the separate ring of frame is configured to provide support for prosthetic leaflet attachment.

49. The prosthetic implant of claim 47, wherein the separate ring of frame allows for crimping such that there are only two layers of frames stacked on top of each other, thus resulting in a smaller catheter profile than a catheter profile resulting from three layers of frames stacked on top of each other.

50. The prosthetic implant of claim 45, further comprising a porous foam, hydrogel, soft lofted cloth skirt, or fabric covering at least a part of the prosthetic implant to provide large surface area.434938-7152-8601.7065472-001024WOPT51. The prosthetic implant of claim 50, wherein the porous foam, hydrogel, soft lofted cloth skirt, or fabric is attached to the part intra annular and / or supra annular.

52. The prosthetic implant of claim 50, wherein the porous foam, hydrogel, soft lofted cloth skirt, or fabric is configured to allow for faster biological growth to aid paravalvular leak resolution and improve device anchoring.

53. The prosthetic implant of claim 50, wherein the porous foam is open cell reticulated or closed cell non reticulated.

54. The prosthetic implant of claim 46, further comprising twisted or rotated eyelets on a flange inflow that are configured to engage with a delivery tube or a delivery catheter.

55. The prosthetic implant of claim 45, wherein a diameter of the outer frame slightly increases post assembly.

56. The prosthetic implant of claim 45 or claim 55, wherein post assembly an inner diameter of the outer frame equals an outer diameter of the inner frame.

57. The prosthetic implant of any one of claims 45, 55, and 56, wherein an equilibrium is reached between the inner frame and the outer frame such that a tight interference fit is created in between the inner frame and the outer frame.

58. A prosthetic implant comprising:an inner frame;an outer frame; anda flange,wherein the prosthetic implant is assembled by a friction fit or an interference fit, allowing for clamping native leaflets and / or sub valvular apparatus between the inner frame and the outer frame, andwherein axial clamping is achieved by attaching the flange to the inner frame that axially overlaps tips of the outer frame.444938-7152-8601.7065472-001024WOPT59. The prosthetic implant of claim 58, further comprising a helical ring including a spring element having a toroidal geometry and a cover covering the spring element, wherein the helical ring is placed around an upper portion of the inner frame and the outer frame, and a surface on one side of the helical ring contacts a substantially horizontally extended portion of the flange allowing for high axial compressibility to provide an active seal.

60. The prosthetic implant of claim 58, further comprising a helical ring including a spring element attached preferentially at 2 or more points of the flange, allowing for elongation and flattening during device crimping allowing for reduced crimp profile.

61. The prosthetic implant of claim 58, further comprising a helical ring including a spring element having a toroidal geometry where an inclined direction of the spring element causes a natural side way bias, allowing for increased conformability in axial and radial directions for purpose of dynamic sealing.

62. The prosthetic implant of claim 59, wherein the helical ring is configured to be placed on a ventricular side of the atrial flange upon deployment of the prosthetic implant to a native heart valve.

63. The prosthetic implant of claim 58, wherein each of anchor tips formed on the outer frame is M-shaped or is a roof style anchor tip, which is designed to result in a smaller space between two anchor tips, compared to triangle-shaped anchor tips, to effectively increase a surface area on anchors of the outer frame.

64. The prosthetic implant of claim 63, wherein a dynamic nature of the outer frame opening allows for the smaller width between the two anchor tips during leaflet capture such that the surface area on the anchors further expand and increase once the leaflets are engaged.454938-7152-8601.7065472-001024WOPT